Orotic acid
From Wikipedia, the free encyclopedia
 |
This article is missing citations or needs footnotes. Please help add inline citations to guard against copyright violations and factual inaccuracies. (October 2007) |
 |
|
|
Orotic acid
|
|
| Systematic (IUPAC) name | |
| 1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C5H4N2O4 |
| Mol. mass | 156.10 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Orotic acid is a heterocyclic compound and an acid; it is also known as pyrimidinecarboxylic acid. Historically, it was believed to be part of the vitamin B complex and was called vitamin B13, but it is now known that it is not a vitamin, but is instead manufactured in the body by intestinal flora.
Its salts, known as orotates, are sometimes used as mineral carriers in some dietary supplements, to increase their bioavailability. Lithium orotate is the most frequently used in this manner.
Contents |
[edit] Pathology
A buildup can lead to orotic aciduria.
In ornithine transcarbamoylase deficiency, a disorder of the urea cycle, excess carbamoyl phospate is converted into orotic acid. This typically leads to increased urinary orotic acid excretion.
[edit] See also
[edit] References
[edit] External links
- MeSH Orotic+Acid
- Overview at ggc.org
- Overview at greatvistachemicals.com
- Overview of Potential Metabolic Antagonists
 |
This article about a heterocyclic compound is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||
Orotic Acid antagonist: "6-Uracilsulfonic Acid, a Sulronic Acid Analog of Orotic Acid" Sheldon B. Greenbaum J. Am. Chem. Soc., 1954, 76 (23), pp 6052–6054
